Thomas J. Shaw Acquires 33,524 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 33,524 shares of the company’s stock in a transaction on Friday, April 11th. The stock was purchased at an average cost of $0.69 per share, for a total transaction of $23,131.56. Following the purchase, the chief executive officer now directly owns 15,201,112 shares in the company, valued at approximately $10,488,767.28. This trade represents a 0.22 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Retractable Technologies Price Performance

NYSE RVP opened at $0.71 on Wednesday. Retractable Technologies, Inc. has a 12-month low of $0.56 and a 12-month high of $1.22. The firm’s 50 day moving average is $0.75 and its 200-day moving average is $0.73. The company has a market capitalization of $21.19 million, a PE ratio of -1.31 and a beta of 2.28. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. Wealthfront Advisers LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 7.58% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on Retractable Technologies in a research report on Saturday. They issued a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.